EarthTrends is reporting that an Indian court has ruled against a large pharmacutical company, which means that India can continue to manfuacture their own drugs without paying exuberant fees to the phramacutical company. Like in Rwanda, India will be producing the drugs to treat people suffering from HIV/AIDs.

Monday’s decision is a major development in the ongoing and often contentious debate over pharmaceutical patents and their impact on access to essential medicines, which has pitted aid agencies and developing countries against large drug companies and the governments of high-income nations.